NASDAQ:CITE Cartica Acquisition (CITE) Stock Price, News & Analysis → Warning: this could blow your mind (From DTI) (Ad) Free CITE Stock Alerts $11.00 -0.10 (-0.90%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$11.00▼$11.1050-Day Range$10.94▼$11.1152-Week Range$10.34▼$12.67Volume3,507 shsAverage Volume19,123 shsMarket Capitalization$109.56 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Get Cartica Acquisition alerts: Email Address Ad Behind the Markets4x Better than Bitcoin4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About Cartica Acquisition Stock (NASDAQ:CITE)Cartica Acquisition Corp does not have any significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to identify and complete a business combination in the technology sector in India. Cartica Acquisition Corp was incorporated in 2021 and is based in Washington, the District of Columbia.Read More CITE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CITE Stock News HeadlinesFebruary 6, 2024 | finance.yahoo.comOwning 48% shares,institutional owners seem interested in Cartica Acquisition Corp (NASDAQ:CITE),See More Headlines Receive CITE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cartica Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today3/29/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorUnclassified Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:CITE CUSIPN/A CIK1848437 Webcarticaspac.com Phone202-367-3003FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares9,960,000Free Float4,514,000Market Cap$109.56 million OptionableNot Optionable Beta0.02 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Suresh Guduru (Age 50)CEO & Chairman Mr. Chad Brian Coad C.F.A. (Age 54)COO & CFO Mr. Suresh Singamsetty (Age 49)Chief Investment Officer & Director Key CompetitorsCapitalworks Emerging Markets AcquisitionNASDAQ:CMCATarget Global Acquisition INASDAQ:TGAAPerception Capital Corp. IIINASDAQ:PFTAChain Bridge INASDAQ:CBRGCompass Digital AcquisitionNASDAQ:CDAQView All CompetitorsInstitutional OwnershipBerkley W R CorpBought 141,110 shares on 2/15/2024Ownership: 4.412%Glazer Capital LLCBought 245,507 shares on 2/15/2024Ownership: 4.224%Citadel Advisors LLCSold 1,049 shares on 2/15/2024Ownership: 0.138%Cowen AND Company LLCSold 55,145 shares on 2/8/2024Ownership: 1.506%Robinson Capital Management LLCSold 4,664 shares on 2/8/2024Ownership: 0.409%View All Institutional Transactions CITE Stock Analysis - Frequently Asked Questions How have CITE shares performed in 2024? Cartica Acquisition's stock was trading at $10.91 on January 1st, 2024. Since then, CITE stock has increased by 0.8% and is now trading at $11.00. View the best growth stocks for 2024 here. Are investors shorting Cartica Acquisition? Cartica Acquisition saw a decrease in short interest in March. As of March 15th, there was short interest totaling 2,500 shares, a decrease of 47.9% from the February 29th total of 4,800 shares. Based on an average daily volume of 16,500 shares, the short-interest ratio is presently 0.2 days. Approximately 0.0% of the shares of the stock are sold short. View Cartica Acquisition's Short Interest. What ETFs hold Cartica Acquisition's stock? ETFs with the largest weight of Cartica Acquisition (NASDAQ:CITE) stock in their portfolio include Robinson Alternative Yield Pre-Merger SPAC ETF (SPAX).SPAC and New Issue ETF (SPCX). Who are Cartica Acquisition's major shareholders? Cartica Acquisition's stock is owned by a variety of retail and institutional investors. Top institutional investors include Berkley W R Corp (4.41%), Glazer Capital LLC (4.22%), Mizuho Securities USA LLC (1.71%), Cowen AND Company LLC (1.51%), Robinson Capital Management LLC (0.41%) and Tuttle Capital Management LLC (0.35%). How do I buy shares of Cartica Acquisition? Shares of CITE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:CITE) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 Media“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyOnly a fool would buy Nvidia today… Porter & CompanyAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cartica Acquisition Corp Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.